Adverse Outcomes and Mortality in Liver Transplant

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Mayo Clinic
Study ID
NCT05477277
Status
Recruiting
Apply to this trial

Conditions

  • Cirrhosis
  • End Stage Liver DIsease
  • Sarcopenia
  • Sarcopenic Obesity

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • MAsS — DIAGNOSTIC_TEST
    Add MAsS to standard of care MRI scan

Study Details

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Key Dates

Start date
Nov 2, 2022
Status verified
Aug 2025
Primary completion
Jul 1, 2026
Completion
Jul 1, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Define MAsS cut-point at transplant evaluation to identify those with high risk for adverse outcomes

Primary Outcome Measure

Muscle assessment score (MAsS) [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic ArizonaPhoenixArizona85259
Elizabeth Carey, MD
480-342-1094

Find similar trials in Phoenix, AZ

By research site
Mayo Clinic Arizona· Phoenix, AZ

Related Studies